Kolexia
Meignan Michel Médecine nucléaire
Meignan Michel
Médecine nucléaire
Hôpital Henri Mondor
Créteil, France
208 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Maladie de Hodgkin Lymphome B diffus à grandes cellules Lymphome B Lymphome folliculaire Lymphome T Lymphome malin non hodgkinien Récidive tumorale locale Lymphome T périphérique

Collaborateurs

Voir plus
Casasnovas Rene-Olivier
Casasnovas Rene-Olivier
Hôpital François Mitterrand, Dijon, France
Cottereau Anne-Segolene
Cottereau Anne-Segolene
Hôpital Cochin, Paris, France
Haioun Corinne
Haioun Corinne
Hôpital Henri Mondor, Créteil, France
Tilly Herve
Tilly Herve
Centre Henri-Becquerel, Rouen, France

Industries

Voir plus
Roche
2 collaboration(s)
Dernière en 2018
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
LyMa101: Phase II Study to Evaluate the Efficacy of Upfront Obinutuzumab in Mantle Cell Lymphoma Patients Treated by DHAP Followed by Autologous Transplantation Plus Obinutuzumab Maintenance Then MRD Driven Maintenance
Essai Clinique (The Lymphoma Academic Research Organisation)   13 mars 2024
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma: Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Adults and Children With Previously Untreated Patients With Aggressive Non-Hodgkin's Lymphoma
Essai Clinique (National Cancer Institute)   22 février 2024
Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Essai Clinique (Stanford University)   21 novembre 2023
Metabolic tumor volume predicts outcome in advanced stage follicular lymphoma patients from the Relevance trial.
Annals of oncology : official journal of the European Society for Medical Oncology   26 octobre 2023
Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology   16 octobre 2023
Validation of the ΔSUV for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine   21 septembre 2023
EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection: Short-Course EPOCH - Rituximab in Untreated CD-20+ HIV-Associated Lymphomas
Essai Clinique (National Cancer Institute)   25 juillet 2023
RADIOMICS REFLECTING BOTH TUMOR AND HOST FEATURES IMPROVES OUTCOME PREDICTION IN FOLLICULAR LYMPHOMA
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Relapsed/Refractory Follicular and Aggressive B-cell Lymphoma: A Phase Ib/II Study of OBINUTUZUMAB Combined to LENALIDOMIDE for the Treatment of Follicular and Relapsed/Refractory Aggressive (DLBCL and MCL) B-cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   16 mars 2023
Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma: Phase 3 Multi-center Randomized Study to Compare Efficacy and Safety of Romidepsin CHOP (Ro-CHOP) Versus CHOP in Patients With Previously Untreated Peripheral T-cell Lymphoma
Essai Clinique (The Lymphoma Academic Research Organisation)   09 janvier 2023